| CASE REPORT |
|
| Year : 2016 | Volume
: 17
| Issue : 3 | Page : 109-113 |
|
|
Percutaneous dual-valve intervention in a high-risk patient with severe aortic and mitral stenosis
Blaz Mrevlje1, Mohamad Aboukura2, Christoph A Nienaber3
1 Trent Cardiac Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
2 University Heart Center Rostock, Rostock, Germany
3 Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK
Correspondence Address:
Prof. Christoph A Nienaber
Royal Brompton and Harefield NHS Foundation Trust and Imperial College, Sydney Street, London, SW3 6NP
UK
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1995-705X.192563
|
|
|
Aortic stenosis is the most frequent and mitral stenosis is the least frequent native single-sided valve disease in Europe. Patients with the combination of severe symptomatic degenerative aortic and mitral stenosis are very rare. Guidelines for the treatment of heart valve diseases are clear for single-valve situations. However, there is no common agreement or recommendation for the best treatment strategy in patients with multiple valve disease and severe concomitant comorbidities. A 76-year-old female patient with the combination of severe degenerative symptomatic aortic and mitral stenosis and several comorbidities including severe obesity, who was found unsuitable surgical candidate by the heart team and unsuitable for two-time general anesthesia in the case of two-step single-valve percutaneous approach by anesthesiologists, underwent successful percutaneous dual-valve single-intervention (transcatheter aortic valve implantation and percutaneous mitral balloon commissurotomy). Percutaneous dual-valve single-intervention is feasible in selected symptomatic high-risk patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
